The overlap of Sjogren's syndrome with other systemic autoimmune diseases

被引:104
作者
Ramos-Casals, Manuel
Brito-Zeron, Pilar
Font, Josep
机构
[1] Hosp Clin Barcelona, Serv Malalties Autoimmunes, IDIBAPS, E-08036 Barcelona, Spain
[2] Univ Barcelona, Sch Med, Dept Autoimmune Dis, Barcelona, Spain
关键词
Sjogren's syndrome; systemic lupus erythematosus; systemic sclerosis; rheumatoid arthritis; antiphospholipid syndrome; vasculitis;
D O I
10.1016/j.semarthrit.2006.08.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To analyze the main diagnostic problems caused by the overlap between Sjogren's syndrome (SS) and other systemic autoimmune diseases (SAD). Methods: We performed a MEDLINE search for articles published between January 1966 and December 2005 that specifically analyzed the overlap between SS and other SAD. We identified a list of diagnostic problems in patients with primary SS who had features considered typical of other SAD. Results: Clinically, the main diagnostic problems occur in SS patients presenting with arthritis, Raynaud phenomenon, cutaneous features (subacute cutaneous lupus erythematosus, purpura, livedo reticularis, erythema nodosum), interstitial pulmonary disease, and cytopenias (leukopenia, thrombocytopenia). Immunologically, antiphospholipid antibodies (aPL) and antineutrophil cytoplasmic antibodies (ANCA) are the most frequent atypical autoantibodies found in primary SS, with a prevalence ranging between 10 and 20%. However, coexisting antiphospholipid syndrome or systemic vasculitis is only detected in around 10% of SS patients with aPL or ANCA. Anti-DNA and anticentromere antibodies have a prevalence of 5 to 10%, but are more closely related to clinical and/or laboratory data suggestive of associated systemic lupus erythematosus and limited systemic sclerosis, respectively, leading to the fulfillment of classification criteria for these diseases in more than 25% of cases. Conclusion: The wide variety of clinical and immunological manifestations of patients with primary SS often overlap with other SAD, making the differentiation between primary SS, SS associated with SAD, and SS-like presentations of some other SAD difficult. This overlap suggests that the current classification criteria are useful in differentiating between autoimmune and non-autoimmune processes but fail to clearly differentiate among SAD. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:246 / 255
页数:10
相关论文
共 62 条
[1]  
Alarcon-Segovia D., 1987, Mixed Connective Tissue Disease and Anti-Nuclear Antibodies, P33
[2]   SJOGRENS SYNDROME IN PROGRESSIVE SYSTEMIC-SCLEROSIS (SCLERODERMA) [J].
ALARCONS.D ;
IBANEZ, G ;
HERNANDE.J ;
VELAZQUE.F ;
GONZALEZ.Y .
AMERICAN JOURNAL OF MEDICINE, 1974, 57 (01) :78-85
[3]  
ANDONOPOULOS AP, 1987, J RHEUMATOL, V14, P1098
[4]   Systemic sclerosis-associated Sjogren's syndrome and relationship to the limited cutaneous subtype - Results of a prospective study of Sicca syndrome in 133 consecutive patients [J].
Avouac, J. ;
Sordet, C. ;
Depinay, C. ;
Ardizonne, M. ;
Vacher-Lavenu, M. C. ;
Sibilia, J. ;
Kahan, A. ;
Allanore, Y. .
ARTHRITIS AND RHEUMATISM, 2006, 54 (07) :2243-2249
[5]   SJOGRENS SYNDROME - A CLINICAL PATHOLOGICAL AND SEROLOGICAL STUDY OF 62 CASES [J].
BLOCH, KJ ;
BUCHANAN, WW ;
WOHL, MJ ;
BUNIM, JJ .
MEDICINE, 1965, 44 (03) :187-+
[6]  
BOSCH X, 1989, J RHEUMATOL, V16, P847
[7]  
Brandt J, 2002, CLIN EXP RHEUMATOL, V20, P80
[8]   EPIDEMIOLOGY OF SARCOIDOSIS [J].
BRESNITZ, EA ;
STROM, BL .
EPIDEMIOLOGIC REVIEWS, 1983, 5 :124-156
[9]  
Caramaschi P, 1997, REV RHUM, V64, P785
[10]  
CASTRO EM, 1990, MED CLIN-BARCELONA, V94, P655